| 0 (0%) | 11-11 17:43 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 16.75 | 1-year : | 19.52 |
| Resists | First : | 14.34 | Second : | 16.71 |
| Pivot price | 13.49  |
|||
| Supports | First : | 10.5 | Second : | 8.73 |
| MAs | MA(5) : | 11.84  |
MA(20) : | 13.97 |
| MA(100) : | 12.12 |
MA(250) : | 10.18 |
|
| MACD | MACD : | -0.6 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 31.2 |
D(3) : | 24.7 |
| RSI | RSI(14): 44.3 |
|||
| 52-week | High : | 18.7 | Low : | 5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ ATRA ] has closed above bottom band by 33.4%. Bollinger Bands are 93.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 12.91 - 12.96 | 12.96 - 13.01 |
| Low: | 11.92 - 11.98 | 11.98 - 12.03 |
| Close: | 12.47 - 12.56 | 12.56 - 12.64 |
Mon, 10 Nov 2025
The Technical Signals Behind (ATRA) That Institutions Follow - news.stocktradersdaily.com
Mon, 10 Nov 2025
Is ATRA stock supported by strong fundamentals - 2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com
Sun, 09 Nov 2025
What analyst consensus says on ATRA stock - Gap Up & Consistent Profit Focused Trading Strategies - newser.com
Fri, 07 Nov 2025
Atara Biotherapeutics (ATRA) Surges 10.0%: Is This an Indication of Further Gains? - Nasdaq
Fri, 07 Nov 2025
The Airbus A320 ATRA flies in IOC configuration for Eurofighter’s AESA radar tests - MSN
Wed, 22 Oct 2025
Tim Passmore receives ATRA Distinguished Fellow Award - Oklahoma State University
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 7 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 21.1 (%) |
| Held by Institutions | 45.7 (%) |
| Shares Short | 129 (K) |
| Shares Short P.Month | 162 (K) |
| EPS | 0.72 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -5.02 |
| Profit Margin | 3 % |
| Operating Margin | 26.8 % |
| Return on Assets (ttm) | 15.7 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | -38.6 % |
| Gross Profit (p.s.) | 0.78 |
| Sales Per Share | 26.87 |
| EBITDA (p.s.) | 3.41 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -64 (M) |
| Levered Free Cash Flow | -64 (M) |
| PE Ratio | 17.44 |
| PEG Ratio | 0 |
| Price to Book value | -2.51 |
| Price to Sales | 0.46 |
| Price to Cash Flow | -1.38 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2024-11-23 |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|